Astrazeneca reported $30.78B in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
AstraZeneca AZN:LN 30781M 1131M
Canopy Growth Corp WEED:CN C$ 1.65B 126.75M
Corcept Therapeutics CORT:US $ 0M 0M
Genmab GEN:DC DK 416M 9M
Novartis NOVN:VX SF 31025M 3218M
Valeant Pharmaceuticals VRX:CN $ 22654M 296M
Zoetis ZTS:US $ 6592M 0M